251 related articles for article (PubMed ID: 10668704)
1. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old.
Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R
Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704
[TBL] [Abstract][Full Text] [Related]
2. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
Qiu C; Winblad B; Fratiglioni L
Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
Yip AG; Brayne C; Easton D; Rubinsztein DC;
J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study.
Slooter AJ; van Duijn CM; Bots ML; Ott A; Breteler MB; De Voecht J; Wehnert A; de Knijff P; Havekes LM; Grobbee DE; Van Broeckhoven C; Hofman A
J Neural Transm Suppl; 1998; 53():17-29. PubMed ID: 9700643
[TBL] [Abstract][Full Text] [Related]
5. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
6. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.
Jonker C; Schmand B; Lindeboom J; Havekes LM; Launer LJ
Arch Neurol; 1998 Aug; 55(8):1065-9. PubMed ID: 9708956
[TBL] [Abstract][Full Text] [Related]
7. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.
Tilvis RS; Strandberg TE; Juva K
J Am Geriatr Soc; 1998 Jun; 46(6):712-5. PubMed ID: 9625186
[TBL] [Abstract][Full Text] [Related]
9. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study.
Winnock M; Letenneur L; Jacqmin-Gadda H; Dallongeville J; Amouyel P; Dartigues JF
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):794-7. PubMed ID: 12023428
[TBL] [Abstract][Full Text] [Related]
11. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.
Henderson AS; Easteal S; Jorm AF; Mackinnon AJ; Korten AE; Christensen H; Croft L; Jacomb PA
Lancet; 1995 Nov; 346(8987):1387-90. PubMed ID: 7475820
[TBL] [Abstract][Full Text] [Related]
13. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.
Brayne C; Harrington CR; Wischik CM; Huppert FA; Chi LY; Xuereb JH; O'Connor DW; Paykel ES
Dementia; 1996; 7(3):169-74. PubMed ID: 8740632
[TBL] [Abstract][Full Text] [Related]
15. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E genotype and lifetime cognitive decline.
Kozauer NA; Mielke MM; Chan GK; Rebok GW; Lyketsos CG
Int Psychogeriatr; 2008 Feb; 20(1):109-23. PubMed ID: 17711604
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
18. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
[TBL] [Abstract][Full Text] [Related]
19. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan.
Asada T; Yamagata Z; Kinoshita T; Kinoshita A; Kariya T; Asaka A; Kakuma T
J Am Geriatr Soc; 1996 Feb; 44(2):151-5. PubMed ID: 8576504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
